Erratum: Adult bone marrow neural crest stem cells and mesenchymal stem cells are not able to replace lost neurons in acute MPTP-lesioned mice (PLoS ONE (2013) 8:5 (e64723) DOI: 10.1371/journal.pone.0064723);Adult Bone Marrow Neural Crest Stem Cells and Mesenchymal Stem Cells Are Not Able to Replace Lost Neurons in Acute MPTP-Lesioned Mice

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Neirinckx, Virginie ^a   Marquet, Alice ^a   Coste, Cécile ^a   Rogister, Bernard ^a,b   Wislet Gendebien, Sabine ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BRAIN CELL; BRAIN DAMAGE; BRAIN TISSUE; CELL DIFFERENTIATION; CELL THERAPY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOUSE; NEURAL CREST CELL; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PHENOTYPE;

MUS;

EID: 84878548589     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0256488     Document Type: Erratum

References (54)

1. Zhao C, Deng W, Gage FH, (2008) Mechanisms and functional implications of adult neurogenesis. Cell 132(4): 645-60.
2. Eriksson PS, Perfilieva E, Björk-Eriksson T, Alborn AM, Nordborg C, et al. (1998) Neurogenesis in the adult human hippocampus. Nat Med 4(11): 1313-7.
3. Hall PA, Watt FM, (1989) Stem cells: the generation and maintenance of cellular diversity. Development 106 (4): 619-33.
4. Patani R, Hollins AJ, Wishart TM, Puddifoot CA, Álvarez S, et al. (2011) Retinoid-independent motor neurogenesis from human embryonic stem cells reveals a medial columnar ground state. Nat Commun 2: 214.
5. Kriks S, Shim JW, Piao J, Ganat Y, Wakeman DR, et al. (2011) Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 480(7378): 547-51.
6. Swistowski A, Peng J, Liu Q, Mali P, Rao MS, et al. (2010) Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. Stem Cells 28(10): 1893-904.
7. Malgrange B, Borgs L, Grobarczyk B, Purnelle A, Ernst P, et al. (2011) Using human pluripotent stem cells to untangle neurodegenerative disease mechanisms. Cell Mol Life Sci 68(4): 635-49.
8. Wislet-Gendebien S, Laudet E, Neirinckx V, Rogister B, (2012) Adult bone marrow: which stem cells for cellular therapy protocols in neurodegenerative disorders? J Biomed Biotechnol 2012: 601560.
9. Khoo ML, Tao H, Meedeniya AC, Mackay-Sim A, Ma DD, (2011) Transplantation of neuronal-primed human bone marrow mesenchymal stem cells in hemiparkinsonian rodents. PLoS One 6(5): 19025.
10. Alexanian AR, Fehlings MG, Zhang Z, Maiman DJ, (2011) Transplanted neurally modified bone marrow-derived mesenchymal stem cells promote tissue protection and locomotor recovery in spinal cord injured rats. Neurorehabil Neural Repair 25(9): 873-80.
11. Levy YS, Bahat-Stroomza M, Barzilay R, Burshtein A, Bulvik S, et al. (2008) Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease. Cytotherapy 10(4): 340-52.
12. Reyes M, Verfaillie CM (2001) Characterization of multipotent adult progenitor cells, a subpopulation of mesenchymal stem cells. Ann N Y Acad Sci 938: 231-3; discussion 233-5.
13. Verfaillie CM (2005) Multipotent adult progenitor cells: an update. Novartis Found Symp 265: 55-61; discussion 61-5, 92-7.
14. D'Ippolito G, Diabira S, Howard GA, Menei P, Roos BA, et al. (2004) Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 117: 2971-81.
15. D'Ippolito G, Howard GA, Roos BA, Schiller PC, (2006) Isolation and characterization of marrow-isolated adult multilineage inducible (MIAMI) cells. Exp Hematol 34(11): 1608-10.
16. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284(5411): 143-7.
17. Dennis JE, Charbord P, (2002) Origin and differentiation of human and murine stroma. Stem Cells 20(3): 205-14.
18. Takashima Y, Era T, Nakao K, Kondo S, Kasuga M, et al. (2007) Neuroepithelial cells supply an initial transient wave of MSC differentiation. Cell 129(7): 1377-88.
19. Nagoshi N, Shibata S, Kubota Y, Nakamura M, Nagai Y, et al. (2008) Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad. Cell Stem Cell 2(4): 392-403.
20. Morikawa S, Mabuchi Y, Niibe K, Suzuki S, Nagoshi N, et al. (2009) Development of mesenchymal stem cells partially originate from the neural crest. Biochem Biophys Res Commun 379: 1114-1119.
21. Glejzer A, Laudet E, Leprince P, Hennuy B, Poulet C, et al. (2011) Wnt1 and BMP2: two factors recruiting multipotent neural crest progenitors isolated from adult bone marrow. Cell Mol Life Sci 68(12): 2101-14.
22. Wislet-Gendebien S, Laudet E, Neirinckx V, Alix P, Leprince P, et al. (2012) Mesenchymal stem cells and neural crest stem cells from adult bone marrow: characterization of their surprising similarities and differences. Cell Mol Life Sciences 69(15): p.2593-608.
23. Jackson-Lewis V, Jakowec M, Burke RE, Przedborski S, (1995) Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 4(3): 257-69.
24. Jackson-Lewis V, Przedborski S, (2007) Protocol for the MPTP mouse model of Parkinson's disease. Nat Protoc 2(1): 141-51.
25. Wislet-Gendebien S, Leprince P, Moonen G, Rogister B, (2003) Regulation of neural markers nestin and GFAP expression by cultivated bone marrow stromal cells. Journal of Cell Science 116: 3295-3302.
26. Phani S, Gonye G, Iacovitti L, (2010) VTA neurons show a potentially protective transcriptional response to MPTP. Brain Res 1343: 1-13.
27. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, et al. (2000) Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 164(2): 247-56.
28. Woodbury D, Schwarz EJ, Prockop DJ, Black IB, (2000) Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61(4): 364-70.
29. Venkataramana NK, Pal R, Rao SAV, Naik AL, Jan M, et al. (2012) Bilateral transplantation of allogenic adult human bone marrow-derived mesenchymal stem cells into the subventricular zone of Parkinson's disease: a pilot clinical study. Stem Cells Int 2012: 931902.
30. Venkataramana NK, Kumar SK, Balaraju S, Radhakrishnan RC, Bansal A, et al. (2010) Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease. Transl Res 155(2): 62-70.
31. Przedborski S, Vila M, (2003) The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease. Ann N Y Acad Sci 991: 189-98.
32. Przedborski S, Jackson-Lewis V, Djaldetti R, Liberatore G, Vila M, et al. (2000) The parkinsonian toxin MPTP: action and mechanism. Restor Neurol Neurosci 16(2): 135-142.
33. Lofrumento DD, Saponaro C, Cianciulli A, De Nuccio F, Mitolo V, et al. (2011) MPTP-induced neuroinflammation increases the expression of pro-inflammatory cytokines and their receptors in mouse brain. Neuroimmunomodulation 18(2): 79-88.
34. Hébert G, Arsaut J, Dantzer R, Demotes-Mainard J, (2003) Time-course of the expression of inflammatory cytokines and matrix metalloproteinases in the striatum and mesencephalon of mice injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a dopaminergic neurotoxin. Neurosci Lett 349(3): 191-5.
35. Ciesielska A, Joniec I, Przybylkowski A, (2003) Dynamics of expression of the mRNA for cytokines and inducible nitric synthase in a murine model of the Parkinson's disease. Acta Neurobiol Exp (Wars) 63(2): 117-26.
36. Li Y, Chen J, Wang L, Zhang L, Lu M, Chopp M, (2001) Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Neurosci Lett 316(2): 67-70.
37. Gibrat C, Saint-Pierre M, Bousquet M, Lévesque D, Rouillard C, et al. (2009) Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions. J Neurochem 109(5): 1469-82.
38. Trzaska KA, Kuzhikandathil EV, Rameshwar P (2007) Specification of a dopaminergic phenotype from adult human mesenchymal stem cells. Stem Cells 25(11): p.2797-808.
39. Tatard VM, D'Ippolito G, Diabira S, Valeyev A, Hackman J, et al. (2007) Neurotrophin-directed differentiation of human adult marrow stromal cells to dopaminergic-like neurons. Bone 40(2): 360-73.
40. Curtis KM, Gomez LA, Schiller PC (2012) Rac1b regulates NT3-stimulated Mek-Erk signaling, directing marrow-isolated adult multilineage inducible (MIAMI) cells toward an early neuronal phenotype. Mol Cell Neurosci 49(2): p.138-48.
41. Sanchez-Ramos JR, (2002) Neural cells derived from adult bone marrow and umbilical cord blood. J Neurosci Res 69(6): 880-93.
42. Liu J, Song L, Jiang C, Liu Y, George J, et al. (2012) Electrophysiological properties and synaptic function of mesenchymal stem cells during neurogenic differentiation- a mini-review. Int J Artif Organs 35(5): 323-37.
43. Montzka K, Lassonczyk N, Tschöke B, Neuss S, Führmann T, et al. (2009) Neural differentiation potential of human bone marrow-derived mesenchymal stromal cells: misleading marker gene expression. BMC Neurosci 10: 16.
44. Tondreau T, Lagneaux L, Dejeneffe M, Massy M, Mortier C, et al. (2004) Bone marrow-derived mesenchymal stem cells already express specific neural proteins before any differentiation. Differentiation 72(7): 319-26.
45. Foudah D, Redondo J, Tredici G, Miloso M (2011) Evaluation of neural markers expression in human mesenchymal stem cells after mesengenic differentiation. Italian Journal of Anatomy and Embryology 16(1).
46. Fu YS, Cheng YC, Lin MY, Cheng H, Chu PM, et al. (2006) Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells 24(1): 115-24.
47. Wang J, Wang X, Sun Z, Wang X, Yang H, et al. (2010) Stem cells from human-exfoliated deciduous teeth can differentiate into dopaminergic neuron-like cells. Stem Cells Dev 19(9): 1375-83.
48. Offen D, Barhum Y, Levy YS, Burshtein A, Panet H, et al. (2007) Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson's disease. J Neural Transm Suppl 72: 133-43.
49. Park HJ, Bang G, Lee BR, Kim HO, Lee PH, (2011) Neuroprotective effect of human mesenchymal stem cells in an animal model of double toxin-induced multiple system atrophy parkinsonism. Cell Transplant 20(6): 827-35.
50. Park HW, Cho JS, Park CK, Jung SJ, Park CH, et al. (2012) Mesenchymal stem cells augment neurogenesis in the subventricular zone and enhance differentiation of neural precursor cells into dopaminergic neurons in the substantia nigra of a Parkinsonian model. Cell Transplant 7(4).
51. Blandini F, Cova L, Armentero MT, Zennaro E, Levandis G, et al. (2010) Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat. Cell Transplant 19(2): 203-17.
52. Chao YX, He BP, Tay SS, (2009) Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease. J Neuroimmunol 216(1-2): 39-50.
53. Cova L, Armentero MT, Zennaro E, Calzarossa C, Bossolasco P, et al. (2010) Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease. Brain Res 1311: 12-27.
54. Neirinckx V, Coste C, Rogister B, Wislet-Gendebien S, (2013) Concise review: adult mesenchymal stem cells, adult neural crest stem cells, and therapy of neurological pathologies: a state of play. Stem Cells Transl Med 2(4): 284-96.